scholarly journals Synthesis of a Morpholino Nucleic Acid (MNA)-Uridine Phosphoramidite, and Exon Skipping Using MNA/2′-O-Methyl Mixmer Antisense Oligonucleotide

Molecules ◽  
2016 ◽  
Vol 21 (11) ◽  
pp. 1582 ◽  
Author(s):  
Suxiang Chen ◽  
Bao Le ◽  
Kamal Rahimizadeh ◽  
Khalil Shaikh ◽  
Narinder Mohal ◽  
...  
RSC Advances ◽  
2017 ◽  
Vol 7 (54) ◽  
pp. 34049-34052 ◽  
Author(s):  
Bao T. Le ◽  
Keiji Murayama ◽  
Fazel Shabanpoor ◽  
Hiroyuki Asanuma ◽  
Rakesh N. Veedu

We investigated the potential of SNA-modified antisense oligonucleotide (AO) for exon-skipping. We found that a 20-mer SNA-AO induced efficient exon-23 skipping in the mouse dystrophin gene transcript.


2021 ◽  
Vol 9 (1) ◽  
Author(s):  
Dominic Scaglioni ◽  
Francesco Catapano ◽  
Matthew Ellis ◽  
Silvia Torelli ◽  
Darren Chambers ◽  
...  

AbstractDuring the last decade, multiple clinical trials for Duchenne muscular dystrophy (DMD) have focused on the induction of dystrophin expression using different strategies. Many of these trials have reported a clear increase in dystrophin protein following treatment. However, the low levels of the induced dystrophin protein have raised questions on its functionality. In our present study, using an unbiased, high-throughput digital image analysis platform, we assessed markers of regeneration and levels of dystrophin associated protein via immunofluorescent analysis of whole muscle sections in 25 DMD boys who received 48-weeks treatment with exon 53 skipping morpholino antisense oligonucleotide (PMO) golodirsen. We demonstrate that the de novo dystrophin induced by exon skipping with PMO golodirsen is capable of conferring a histological benefit in treated patients with an increase in dystrophin associated proteins at the dystrophin positive regions of the sarcolemma in post-treatment biopsies. Although 48 weeks treatment with golodirsen did not result in a significant change in the levels of fetal/developmental myosins for the entire cohort, there was a significant negative correlation between the amount of dystrophin and levels of regeneration observed in different biopsy samples. Our results provide, for the first time, evidence of functionality of induced dystrophin following successful therapeutic intervention in the human.


2006 ◽  
Vol 59 (5) ◽  
pp. 690-694 ◽  
Author(s):  
Yasuhiro Takeshima ◽  
Mariko Yagi ◽  
Hiroko Wada ◽  
Kazuto Ishibashi ◽  
Atsushi Nishiyama ◽  
...  

2006 ◽  
Vol 16 (9-10) ◽  
pp. 686
Author(s):  
A. Aartsma-Rus ◽  
C.L. de Winter ◽  
W.E. Kaman ◽  
A.A.M. Janson ◽  
J.C.T. van Deutekom

2007 ◽  
Vol 8 (1) ◽  
pp. 57 ◽  
Author(s):  
Abbie M Adams ◽  
Penny L Harding ◽  
Patrick L Iversen ◽  
Catherine Coleman ◽  
Sue Fletcher ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document